Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 2 diabetes
MedTech
FDA clears Biolinq's color-coded sensor patch for glucose ranges
After raising $100 million in funding, Biolinq has obtained a groundbreaking FDA clearance for its Shine needle-free continuous glucose monitor.
Conor Hale
Sep 29, 2025 11:30am
Sparrow flits forward with $95M for midstage diabetes asset
Sep 24, 2025 11:22am
Lilly rounds out orforglipron data ahead of obesity filings
Sep 17, 2025 9:00am
Medtronic debuts Abbott Instinct CGM as MiniMed 780G enters T2D
Sep 2, 2025 11:00am
Novo seeks obesity refresh with $550M Replicate deal
Aug 28, 2025 7:00am
Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients
Aug 26, 2025 6:45am
